AD-218
- Generic Name
- AD-218
A Study to Evaluate the Efficacy and Safety of AD-218
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 520
- Registration Number
- NCT05400317
- Locations
- 🇰🇷
Yeongnam University Hospital, Daegu, Nam-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath